Edinburgh Research Explorer

Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome

Research output: Contribution to journalArticle

  • Paolo Giannetti
  • Marios Politis
  • Paul Su
  • Federico E Turkheimer
  • Omar Malik
  • Shiva Keihaninejad
  • Kit Wu
  • Adam Waldman
  • Richard Reynolds
  • Richard Nicholas
  • Paola Piccini

Related Edinburgh Organisations

Original languageEnglish
Pages (from-to)110-9
Number of pages10
JournalBrain
Volume138
Issue numberPt 1
DOIs
Publication statusPublished - Jan 2015

Abstract

The most accurate predictor of the subsequent development of multiple sclerosis in clinically isolated syndrome is the presence of lesions at magnetic resonance imaging. We used in vivo positron emission tomography with (11)C-(R)-PK11195, a biomarker of activated microglia, to investigate the normal-appearing white matter and grey matter of subjects with clinically isolated syndrome to explore its role in the development of multiple sclerosis. Eighteen clinically isolated syndrome and eight healthy control subjects were recruited. Baseline assessment included: history, neurological examination, expanded disability status scale, magnetic resonance imaging and PK11195-positron emission tomography scans. All assessments except the PK11195-positron emission tomography scan were repeated over 2 years. SUPERPK methodology was used to measure the binding potential relative to the non-specific volume, BPND. We show a global increase of normal-appearing white matter PK11195 BPND in clinically isolated syndrome subjects compared with healthy controls (P = 0.014). Clinically isolated syndrome subjects with T2 magnetic resonance imaging lesions had higher PK11195 BPND in normal-appearing white matter (P = 0.009) and their normal-appearing white matter PK11195 BPND correlated with the Expanded Disability Status Scale (P = 0.007; r = 0.672). At 2 years those who developed dissemination in space or multiple sclerosis, had higher PK11195 BPND in normal-appearing white matter at baseline (P = 0.007 and P = 0.048, respectively). Central grey matter PK11195 BPND was increased in subjects with clinically isolated syndrome compared to healthy controls but no difference was found in cortical grey matter PK11195 BPND. Microglial activation in clinically isolated syndrome normal-appearing white matter is diffusely increased compared with healthy control subjects and is further increased in those who have magnetic resonance imaging lesions. Furthermore microglial activation in clinically isolated syndrome normal-appearing white matter is also higher in those subjects who developed multiple sclerosis at 2 years. Our finding, if replicated in a larger study, could be of prognostic value and aid early treatment decisions in clinically isolated syndrome.

    Research areas

  • Adult, Antineoplastic Agents, Brain, Disability Evaluation, Female, Humans, Isoquinolines, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Positron-Emission Tomography, Protein Binding, Retrospective Studies, Statistics, Nonparametric, White Matter, Young Adult, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.

ID: 45345399